Radiotherapy to bone has utility in multifocal metastatic renal carcinoma

Area of Science:

• Oncology
• Radiation Oncology
• Palliative Care

Background:

• Bone metastases from renal cell carcinoma (RCC) are often considered radioresistant.
• Effective palliative strategies for osseous metastases in RCC are crucial for patient quality of life.

Purpose of the Study:

• To evaluate the efficacy of palliative radiotherapy for bone metastases in carefully selected renal cell carcinoma patients.
• To test the hypothesis that irradiation provides adequate palliation for osseous metastases in RCC.

Main Methods:

• Retrospective review of 28 patients with metastatic renal cell carcinoma to bone.
• Analysis of 36 palliative radiotherapy treatments for 36 osseous metastatic sites.
• Follow-up until death to assess treatment outcomes, including need for repeat radiotherapy or surgery.

Main Results:

• 91.7% of sites received only radiotherapy for palliation.
• 69.5% of sites did not require subsequent radiotherapy.
• Median return to pre-treatment pain and functional levels was 2 months and 1 month, respectively.

Conclusions:

• Palliative radiotherapy for osseous metastases in renal cell carcinoma patients provides short-term pain control.
• Radiotherapy effectively prevents fractures and reduces the need for surgery in this patient population.
• Irradiation is a viable palliative option for carefully selected patients with multifocal bone metastases from RCC.